NEW YORK, May 12 (GenomeWeb News) - 454 Life Sciences has signed an exclusive distribution agreement with Roche for its sequencing technology in a deal potentially worth $62 million to the sequencing upstart. 454 has also named a new chief executive as CuraGen Jonathan Rothberg has stepped down.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.